Detail akcie Smith & Nephew Depository Receipt online

Business Summary: Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Financial Summary: BRIEF: For the six months ended 29 June 2024, Smith & Nephew plc (ADR) revenues increased 3% to $2.83B. Net income increased 24% to $214M. Revenues reflect Orthopaedics segment increase of 4% to $1.15B, Sports Medicine & ENT segment increase of 5% to $888M, Advanced Wound Management segment increase of less than 1% to $790M, Emerging &internatiuonal market segment increase of 8% to $493M.